SMTL ID : 3g5d.2 (1 other biounit)

Kinase domain of cSrc in complex with Dasatinib

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.20 Å

Oligo State

monomer

Ligands

1 x 1N1: N-(2-CHLORO-6-METHYLPHENYL)-2-({6-[4-(2-HYDROXYETHYL)PIPERAZIN-1-YL]-2-METHYLPYRIMIDIN-4-YL}AMINO)-1,3-THIAZOLE-5-CARBOXAMIDE(Non-covalent)

1N1.1: 19 residues within 4Å: Chain A: L.26, V.34, A.46, I.47, K.48, E.63, M.67, V.76, I.89, T.91, E.92, Y.93, M.94, S.95, K.96, G.97, L.146, A.156, D.157 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:L.26, A:A.46, A:K.48, A:K.48, A:I.89, A:T.91, A:Y.93 Hydrogen bonds: A:T.91, A:T.91, A:M.94, A:M.94

1 x GOL: GLYCEROL(Non-functional Binders)

GOL.2: 4 residues within 4Å: Chain A: P.114, Q.115, D.118, L.151 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:Q.115 Water bridges: A:Q.115, A:D.118

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Getlik, M. et al., Hybrid compound design to overcome the gatekeeper T338M mutation in cSrc. J.Med.Chem. (2009)

Release Date

2009-06-02

Peptides

Proto-oncogene tyrosine-protein kinase Src: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

Proto-oncogene tyrosine-protein kinase Src

Related Entries With Identical Sequence